AbbVie reported a net income of $36 million, or 1 cent a share, down from $2.8 billion, or $1.88 a share, in the year-earlier quarter. The latest adjusted earnings came to $2.92 a share.
"We successfully completed the transformative Allergan acquisition and delivered another year of strong results in 2020, despite the challenges presented by the global pandemic," Chairman and CEO Richard Gonzalez said in a statement.
"Based on our broad portfolio of diversified growth assets and the robust momentum of our business, we expect impressive growth again in 2021."
Curious about what Jim Cramer and his team at Action Alerts PLUS are watching in the markets? Watch Cramer's exclusive members-only Daily Rundown show on Action Alerts PLUS following TheStreet Live.